<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04360109</url>
  </required_header>
  <id_info>
    <org_study_id>PI19/01524</org_study_id>
    <nct_id>NCT04360109</nct_id>
  </id_info>
  <brief_title>Study of the Association Between Presbycusis With the Incidence of Frailty</brief_title>
  <official_title>Study of the Association Between Presbycusis With the Incidence of Frailty. Intake of Polyphenols for the Prevention of Presbycusis: Effects on Frailty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad Europea de Madrid</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidad Europea de Madrid</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the project is to establish the association between presbycusis and the
      incidence of frailty in humans in order to establish hearing loss with age as another index
      for the diagnosis of frailty; As well as studying the effect of exposure to polyphenols in
      the diet on presbycusis and frailty. Human study: volunteers between 60 and 99 years old, men
      and women during a period of 6 months, questions and answers, audiometries, study of
      fragility, analysis of antioxidants in blood, and samples of urine will be measured Total
      polyphenols and oxidant capacity.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2020</start_date>
  <completion_date type="Anticipated">November 2022</completion_date>
  <primary_completion_date type="Anticipated">November 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>6 Months</target_duration>
  <primary_outcome>
    <measure>Auditory function</measure>
    <time_frame>6 months</time_frame>
    <description>study by pure tone audiometry, calculating an average of the thresholds of hearing at 0.5, 1, 2 and 4 kilohertz classifying according to their hearing thresholds to the participants in: normal hearing ≤ 25decibel, slight hearing loss = 26-40 decibel; Y moderate-greater hearing loss&gt; 40 decibel (according to the World Health Organization).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Frailty</measure>
    <time_frame>6 months</time_frame>
    <description>Fragility will be determined at the beginning and at the end of the study period using the 5 Fried indexes: weakness, low speed, low physical activity, exhaustion and weight loss. Participants with 3 or more criteria are classified as fragile, with 1-2 criteria as pre-fragile, and those without any criteria are not considered fragile.
Thus, individuals will be classified in the analyzes as non-fragile, pre-fragile and fragile.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Determination of total polyphenols in urine</measure>
    <time_frame>measured twice in each volunteer, at the beginning and end of the study period (6 months)</time_frame>
    <description>24-hour urine samples using the method Folin -Ciocalteu.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood analysis,</measure>
    <time_frame>It will be performed at the beginning and at end of the study period (6 months)</time_frame>
    <description>routine biochemistry and determination of: carotenoids, vitamins E and D</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Microbiota</measure>
    <time_frame>It will be performed at the beginning and at end of the study period (6 months)</time_frame>
    <description>Stool microbiota analysis</description>
  </secondary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Presbycusis</condition>
  <condition>Frailty Syndrome</condition>
  <condition>Oxidative Stress</condition>
  <eligibility>
    <study_pop>
      <textblock>
        People who meet the inclusion and exclusion criteria and who attend the ENT or geriatrics
        clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age

        Exclusion Criteria:

          -  Disease of the hearing system

          -  Serious illness (e.g. tumor)

          -  Dementia

          -  Total dependence
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carolina S Rodríguez</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidad Europea de Madrid</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rodríguez</last_name>
    <phone>91- 683 93 60</phone>
    <phone_ext>2397</phone_ext>
    <email>carolina.sanchez2@universidadeuropea.es</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Universitario de Getafe</name>
      <address>
        <city>Getafe</city>
        <state>Madrid</state>
        <zip>28905</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Maria Garrote</last_name>
      <phone>670955327</phone>
      <phone_ext>2397</phone_ext>
      <email>m.garrotega@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Cristina Alonso</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>March 9, 2020</study_first_submitted>
  <study_first_submitted_qc>April 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 24, 2020</study_first_posted>
  <last_update_submitted>April 22, 2020</last_update_submitted>
  <last_update_submitted_qc>April 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad Europea de Madrid</investigator_affiliation>
    <investigator_full_name>Carolina Sánchez Rodríguez</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Presbycusis</mesh_term>
    <mesh_term>Frailty</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

